Pediatric Drugs

Acknowledgement to Referees

Deferred Consent in Pediatric Drug Trials: Moving from Why to How

Martin Offringa, Terry P. Klassen

Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance

Giuseppe Barone, Ailish Barry, Francisco Bautista, Bénédicte Brichard, Anne-Sophie Defachelles, Fiona Herd, Carla Manzitti, Dirk Reinhardt, Pedro M. Rubio, Aleksandra Wieczorek, Max M. van Noesel

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

Susanna Esposito, Timothy J. Carrothers, Todd Riccobene, Gregory G. Stone, Michal Kantecki

Deferred Consent in Neonatal Clinical Research: Why, When, How?

Dilini I. Imbulana, Louise S. Owen, Trisha M. Prentice, Peter G. Davis, Brett J. Manley

Use of Furosemide and Chlorothiazide Combination Continuous Infusion in Furosemide-Refractory Patients in the Pediatric Intensive Care Unit: A Retrospective Cohort Study

Summer R. Record, Aaron A. Harthan, Sandeep Tripathi

Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical Trials

Stephen V. Faraone, Roberto Gomeni, Joseph T. Hull, Gregory D. Busse, Zare Melyan, Jonathan Rubin, Azmi Nasser

Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants

Adriana del Pilar Montealegre-Pomar, Nathalie Charpak

Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis

Hannah A. Blair

Teriflunomide: Pediatric First Approval

Julia Paik

Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

Susanna Esposito, Timothy J. Carrothers, Todd Riccobene, Gregory G. Stone, Michal Kantecki